{"id":"sucrase","rwe":[],"tags":[],"phase":"discontinued","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"discontinued","trials":["NCT05045495","NCT05480761","NCT05688826","NCT03898856","NCT06770907","NCT03897517","NCT02784067","NCT01957098","NCT07309601","NCT05159115","NCT04604275","NCT01914003","NCT00302302"],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"brandName":"Sucrase","companyId":"university-of-miami","ecosystem":[],"mechanism":{"target":"","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"University of Miami","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Sucrase","indications":{"approved":[{"name":"Sucrase-isomaltase deficiency","diseaseId":"sucrase-isomaltase-deficiency","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05045495","phase":"N/A","title":"Adult Pilot Study to Establish the Reference Ranges and Optimal Cut-offs for Oral 50g Sucrose Challenge Test & 13C-Sucrose Breath Test for CSID Cases (Previously Diagnosed Sucraid Responders) & Contro","status":"COMPLETED","sponsor":"QOL Medical, LLC","isPivotal":false,"enrollment":211,"indication":"Congenital Sucrase-Isomaltase Deficiency","completionDate":"2022-02-28"},{"nctId":"NCT05480761","phase":"Phase 4","title":"Evaluation of a 7-Day Therapeutic Trial Dose of Commercial Sucraid® (Sacrosidase) Oral Solution for Alleviating Congenital Sucrase-Isomaltase Deficiency (CSID) Symptoms in Pediatric Subjects With Low,","status":"TERMINATED","sponsor":"QOL Medical, LLC","isPivotal":false,"enrollment":312,"indication":"Congenital Sucrase-Isomaltase Deficiency, CSID","completionDate":"2024-09-18"},{"nctId":"NCT05688826","phase":"NA","title":"Comparison of Sugar Load Between Normal and Functional Variants of Sucrase-isomaltase Genes in IBS","status":"COMPLETED","sponsor":"Region Skane","isPivotal":false,"enrollment":40,"indication":"Sucrase-Isomaltase Deficiency, Irritable Bowel Syndrome","completionDate":"2025-06-23"},{"nctId":"NCT03898856","phase":"Phase 4","title":"Yield of Diagnostic Tests and Management of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients: A Pilot Study","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","isPivotal":false,"enrollment":93,"indication":"Chronic Diarrhea of Unknown Origin","completionDate":"2025-01-30"},{"nctId":"NCT06770907","phase":"N/A","title":"Genetic Carbohydrate Maldigestion As a Model to Study Food Hypersensitivity Mechanism and Guide Personalised Treatment Using a Non-invasive Multiparametric Test (WORK PACKAGE 2)","status":"NOT_YET_RECRUITING","sponsor":"University of Nottingham","isPivotal":false,"enrollment":80,"indication":"Sucrase Isomaltase Deficiency","completionDate":"2026-03"},{"nctId":"NCT03897517","phase":"NA","title":"Effect of Proprietary Botanical Blend on Glycemic Control and Post-prandial Carbohydrate Absorption in Overweight, Insulin Resistant Adult Men and Women","status":"UNKNOWN","sponsor":"Plexus Worldwide","isPivotal":false,"enrollment":30,"indication":"Hyperglycemia, Carbohydrate","completionDate":"2019-12-31"},{"nctId":"NCT02784067","phase":"Phase 4","title":"A Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution ","status":"WITHDRAWN","sponsor":"QOL Medical, LLC","isPivotal":false,"enrollment":0,"indication":"Genetic Sucrase-Isomaltase Deficiency","completionDate":"2017-12"},{"nctId":"NCT01957098","phase":"NA","title":"The Effects of L-Arabinose and D-xylose on Intestinal Sucrase Activity in Man","status":"COMPLETED","sponsor":"University of Copenhagen","isPivotal":false,"enrollment":14,"indication":"Insulin Resistance","completionDate":"2007-05"},{"nctId":"NCT07309601","phase":"NA","title":"Comparison of a Meal Load Between Normal and Functional Variants of the Sucrase-isomaltase (SI) Gene in IBS","status":"NOT_YET_RECRUITING","sponsor":"Region Skane","isPivotal":false,"enrollment":70,"indication":"IBS - Irritable Bowel Syndrome, Sucrase-Isomaltase Deficiency","completionDate":"2030-02-01"},{"nctId":"NCT05159115","phase":"NA","title":"Sucrase-isomaltase Deficiency as a Cause of Irritable Bowel Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Lovisenberg Diakonale Hospital","isPivotal":false,"enrollment":80,"indication":"Irritable Bowel Syndrome, Sucrose Intolerance Due to Sucrase-Isomaltase Deficiency","completionDate":"2027-12-31"},{"nctId":"NCT04604275","phase":"Phase 2","title":"Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure","status":"TERMINATED","sponsor":"University of Miami","isPivotal":false,"enrollment":3,"indication":"Short Gut Syndrome","completionDate":"2024-09-01"},{"nctId":"NCT01914003","phase":"N/A","title":"A Multi-Center Study of the Prevalence of Known Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Variants and Functional Sucrase Activity by 13C-Sucrose Breath Test in Children With Chronic Dia","status":"COMPLETED","sponsor":"QOL Medical, LLC","isPivotal":false,"enrollment":53,"indication":"Congenital Sucrase-isomaltase Deficiency (CSID)","completionDate":"2015-07"},{"nctId":"NCT00302302","phase":"Phase 1","title":"The Effects of Increasing Doses of L-arabinose in a Sucrose Rich Meal on Intestinal Sucrase Activity in Man","status":"COMPLETED","sponsor":"University of Copenhagen","isPivotal":false,"enrollment":15,"indication":"Blood Glucose","completionDate":"2006-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}